| CA1 |
CA1: Carbonic anhydrase 1 |
SLC4A1 |
SLC4A1, AE1, DI, EPB3: Band 3 anion transport protein |
13.880 |
Evidence |
|
| DOK1 |
DOK1: Docking protein 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
13.860 |
Evidence |
|
| ILK |
ILK, ILK1, ILK2: Integrin-linked protein kinase |
SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
13.860 |
Evidence |
|
| TRAF1 |
TRAF1, EBI6: TNF receptor-associated factor 1 |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
13.860 |
Evidence |
O
|
| SOS1 |
SOS1: Son of sevenless homolog 1 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
13.860 |
Evidence |
|
| BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PASK |
PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase |
13.860 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
13.860 |
Evidence |
|
| MECP2 |
MECP2: Methyl-CpG-binding protein 2 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
13.860 |
Evidence |
|
| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
13.860 |
Evidence |
|
| GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
13.860 |
Evidence |
|
| MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
13.860 |
Evidence |
|
| CRKL |
CRKL: Crk-like protein |
PRKAA1 |
IPI00011891 |
13.860 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
PRKAA1 |
IPI00011891 |
13.860 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
13.860 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
ANGPTL3 |
ANGPTL3, ANGPT5, UNQ153/PRO179: Angiopoietin-related protein 3 precursor |
13.860 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
13.860 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
PRKAA1 |
IPI00011891 |
13.860 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
NEK3 |
NEK3: Serine/threonine-protein kinase Nek3 |
13.860 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
13.860 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
13.860 |
Evidence |
|
| CMA1 |
CMA1, CYH, CYM: Chymase precursor |
C6 |
C6: Complement component C6 precursor |
13.860 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
SCML2 |
SCML2: Sex comb on midleg-like protein 2 |
13.860 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
IRS1 |
IRS1: Insulin receptor substrate 1 |
13.860 |
Evidence |
|
| BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
VDAC1 |
VDAC1, VDAC: Voltage-dependent anion-selective channel protein 1 |
13.860 |
Evidence |
|
| IGFBP1 |
IGFBP1, IBP1: Insulin-like growth factor-binding protein 1 precursor |
IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
13.860 |
Evidence |
|